136 related articles for article (PubMed ID: 29053049)
1. A Bayesian Meta-analysis Method for Estimating Risk Difference of Rare Events.
Tang Y; Tang Q; Yu Y; Wen S
J Biopharm Stat; 2018; 28(3):550-561. PubMed ID: 29053049
[TBL] [Abstract][Full Text] [Related]
2. Bayesian meta-experimental design: evaluating cardiovascular risk in new antidiabetic therapies to treat type 2 diabetes.
Ibrahim JG; Chen MH; Xia HA; Liu T
Biometrics; 2012 Jun; 68(2):578-86. PubMed ID: 21955084
[TBL] [Abstract][Full Text] [Related]
3. Bayesian sequential meta-analysis design in evaluating cardiovascular risk in a new antidiabetic drug development program.
Chen MH; Ibrahim JG; Amy Xia H; Liu T; Hennessey V
Stat Med; 2014 Apr; 33(9):1600-18. PubMed ID: 24343859
[TBL] [Abstract][Full Text] [Related]
4. A Bayesian meta-analytic approach for safety signal detection in randomized clinical trials.
Odani M; Fukimbara S; Sato T
Clin Trials; 2017 Apr; 14(2):192-200. PubMed ID: 28059578
[TBL] [Abstract][Full Text] [Related]
5. A Bayesian sensitivity study of risk difference in the meta-analysis of binary outcomes from sparse data.
Vázquez-Polo FJ; Moreno E; Negrín MA; Martel M
Expert Rev Pharmacoecon Outcomes Res; 2015 Apr; 15(2):317-22. PubMed ID: 25673174
[TBL] [Abstract][Full Text] [Related]
6. Detecting outlying trials in network meta-analysis.
Zhang J; Fu H; Carlin BP
Stat Med; 2015 Aug; 34(19):2695-707. PubMed ID: 25851533
[TBL] [Abstract][Full Text] [Related]
7. Bayesian indirect and mixed treatment comparisons across longitudinal time points.
Ding Y; Fu H
Stat Med; 2013 Jul; 32(15):2613-28. PubMed ID: 23229717
[TBL] [Abstract][Full Text] [Related]
8. Bayesian robustness in meta-analysis for studies with zero responses.
Vázquez FJ; Moreno E; Negrín MA; Martel M
Pharm Stat; 2016 May; 15(3):230-7. PubMed ID: 26913715
[TBL] [Abstract][Full Text] [Related]
9. Bayesian random effects meta-analysis of trials with binary outcomes: methods for the absolute risk difference and relative risk scales.
Warn DE; Thompson SG; Spiegelhalter DJ
Stat Med; 2002 Jun; 21(11):1601-23. PubMed ID: 12111922
[TBL] [Abstract][Full Text] [Related]
10. Comments on "A Bayesian meta-analysis method for estimating risk difference of rare events".
Holzhauer B; Glimm E
J Biopharm Stat; 2018; 28(5):1015-1017. PubMed ID: 29902101
[No Abstract] [Full Text] [Related]
11. Random-effects meta-analysis of few studies involving rare events.
Günhan BK; Röver C; Friede T
Res Synth Methods; 2020 Jan; 11(1):74-90. PubMed ID: 31348846
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular events and all-cause mortality associated with sulphonylureas compared with other antihyperglycaemic drugs: A Bayesian meta-analysis of survival data.
Bain S; Druyts E; Balijepalli C; Baxter CA; Currie CJ; Das R; Donnelly R; Khunti K; Langerman H; Leigh P; Siliman G; Thorlund K; Toor K; Vora J; Mills EJ
Diabetes Obes Metab; 2017 Mar; 19(3):329-335. PubMed ID: 27862902
[TBL] [Abstract][Full Text] [Related]
13. A practical Bayesian adaptive design incorporating data from historical controls.
Psioda MA; Soukup M; Ibrahim JG
Stat Med; 2018 Nov; 37(27):4054-4070. PubMed ID: 30033617
[TBL] [Abstract][Full Text] [Related]
14. Exact and efficient inference procedure for meta-analysis and its application to the analysis of independent 2 x 2 tables with all available data but without artificial continuity correction.
Tian L; Cai T; Pfeffer MA; Piankov N; Cremieux PY; Wei LJ
Biostatistics; 2009 Apr; 10(2):275-81. PubMed ID: 18922759
[TBL] [Abstract][Full Text] [Related]
15. Low-event-rate meta-analyses of clinical trials: implementing good practices.
Shuster JJ; Walker MA
Stat Med; 2016 Jun; 35(14):2467-78. PubMed ID: 26728099
[TBL] [Abstract][Full Text] [Related]
16. Guidance on the implementation and reporting of a drug safety Bayesian network meta-analysis.
Ohlssen D; Price KL; Xia HA; Hong H; Kerman J; Fu H; Quartey G; Heilmann CR; Ma H; Carlin BP
Pharm Stat; 2014; 13(1):55-70. PubMed ID: 24038897
[TBL] [Abstract][Full Text] [Related]
17. Meta-analysis of aggregate data on medical events.
Holzhauer B
Stat Med; 2017 Feb; 36(5):723-737. PubMed ID: 27859465
[TBL] [Abstract][Full Text] [Related]
18. The Yusuf-Peto method was not a robust method for meta-analyses of rare events data from antidepressant trials.
Sharma T; Gøtzsche PC; Kuss O
J Clin Epidemiol; 2017 Nov; 91():129-136. PubMed ID: 28802674
[TBL] [Abstract][Full Text] [Related]
19. How to use prior knowledge and still give new data a chance?
Weber K; Hemmings R; Koch A
Pharm Stat; 2018 Jul; 17(4):329-341. PubMed ID: 29667367
[TBL] [Abstract][Full Text] [Related]
20. Continuous event monitoring via a Bayesian predictive approach.
Di J; Wang D; Brashear HR; Dragalin V; Krams M
Pharm Stat; 2016; 15(2):109-22. PubMed ID: 26643012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
